[Prophylaxis of hepatic veno-occlusive disease by low-molecular-weight heparin and lipo- prostaglandin E1 after allogeneic peripheral blood stem cell transplantation].
Di Yi Jun Yi Da Xue Xue Bao
; 23(5): 494, 497, 2003 May.
Article
em Zh
| MEDLINE
| ID: mdl-12754143
ABSTRACT
To study the effects of low-molecular-weight heparin and lipid microspheres containing prostaglandin E(1) (lipo PGE) in preventing hepatic veno-occlusive disease after allogeneic peripheral blood stem cell transplantation, we observed 21 cases of allogeneic stem cell transplantation, in which the combined treatments were administered from day -7 to day +30. As a result, only 2 of these cases developed hepatic veno-occlusive disease, without obvious treatment-related adverse effects, suggesting the safety and effectiveness of the combined treatment using low-molecular-weight heparin and lipo PGE1 in the prevention of hepatic veno-occlusive disease after allogenetic stem cell transplantation.
Buscar no Google
Base de dados:
MEDLINE
Assunto principal:
Hepatopatia Veno-Oclusiva
/
Alprostadil
/
Heparina de Baixo Peso Molecular
/
Transplante de Células-Tronco de Sangue Periférico
Idioma:
Zh
Ano de publicação:
2003
Tipo de documento:
Article